Wegovy Weight Loss Pill — Complete Guide for Holroyd Pharmacy

For years, effective medical weight loss meant weekly injections. That changed on 11 June 2026, when the UK's medicines regulator the MHRA approved the Wegovy weight loss pill, making it the first daily GLP-1 tablet ever licensed for weight management in the United Kingdom.

If the idea of self-injecting has kept you from exploring medical weight loss treatment, this development could change everything. The Wegovy pill contains the same proven active ingredient as the injectable version semaglutide but in a convenient once-daily tablet you simply swallow each morning.

At Holroyd Pharmacy, we believe every patient deserves clear, honest information before starting any treatment. This guide covers exactly what the Wegovy pill is, how it works, what the clinical trial results show, who qualifies, and what to expect when you start. Whether you're entirely new to weight loss medication or considering switching from another treatment, you'll find the answers you need right here.

What Is the Wegovy Weight Loss Pill?

The Wegovy pill is an oral form of semaglutide, developed by Danish pharmaceutical company Novo Nordisk. Semaglutide is a GLP-1 receptor agonist a class of medicine that mimics a natural gut hormone your body releases after eating.

Until now, semaglutide has been available in tablet form only at the lower doses used for type 2 diabetes management (under the brand name Rybelsus). The Wegovy pill is different: it reaches a daily maintenance dose of 25mg, specifically designed to deliver weight loss results comparable to the injectable Wegovy pen.

The UK Approval and What It Means

The MHRA granted its licence on 11 June 2026, making the UK the first country in Europe to approve an oral GLP-1 receptor agonist for weight loss. The approval followed strong clinical evidence and the earlier FDA approval in the United States in December 2025, where the pill surpassed three million prescriptions within its first months on the market.

For now, the Wegovy pill is available in the UK on a private prescription basis only. NHS coverage depends on a separate cost-effectiveness review by NICE, which is still ongoing.

How Does the Wegovy Pill Work?

After you take the tablet, semaglutide works on GLP-1 receptors throughout your body particularly in the brain and digestive system. Here is what that looks like in practice:

• Appetite suppression: Semaglutide acts on appetite centres in the brain, reducing hunger signals so you feel less compelled to eat.
• Increased fullness: It enhances the sensation of satiety after meals, so smaller portions leave you feeling satisfied for longer.
• Slower stomach emptying: The medication slows the rate at which food leaves the stomach, helping to prevent the sharp hunger spikes that often trigger overeating.

Together, these effects make it significantly easier to maintain a calorie deficit the fundamental requirement for weight loss without relying purely on willpower.

How the Pill Reaches Your Bloodstream

One of the most impressive aspects of the Wegovy pill is the science behind its formulation. Unlike injectable semaglutide, which passes directly into the bloodstream, an oral tablet must survive stomach acid and be absorbed through the gut wall. Novo Nordisk achieved this by encapsulating the semaglutide molecule in a way that shields it from stomach acid, allowing effective absorption when the tablet is taken correctly on an empty stomach with a small sip of plain water.

Wegovy Pill Clinical Trial Results

The approval is built on the OASIS 4 clinical trial, a 64-week, randomised, double-blind, placebo-controlled study published in the New England Journal of Medicine in September 2025.

What the Trial Found

• Participants taking the 25mg daily Wegovy pill lost an average of 16.6% of their starting body weight over 64 weeks, compared to just 2.7% in the placebo group.
• Around 1 in 3 participants lost 20% or more of their body weight.
• The average participant weighed approximately 106kg with a BMI of around 38 — results that are directly relevant to typical candidates for treatment in the UK.
• Beyond weight loss, participants showed meaningful improvements in blood sugar levels, cholesterol, and other cardiovascular risk factors.

The pill delivers results closely comparable to the standard injectable dose. If needles have been a barrier for you, the difference in outcomes is modest but the difference in convenience could be life-changing.

Who Can Take the Wegovy Weight Loss Pill?

The Wegovy pill is licensed for adults who meet one of the following criteria:

• A BMI of 30 or above (classified as obese), or
• A BMI of 27 or above (classified as overweight) plus at least one weight-related health condition, such as high blood pressure, high cholesterol, or pre-diabetes.

It is prescribed alongside a calorie-controlled diet, increased physical activity, and ongoing support from a healthcare professional. It is not suitable for everyone, and a clinical consultation is required before starting treatment.

Who Should Not Take the Wegovy Pill?

The Wegovy pill is not suitable if you:

• Have a personal or family history of medullary thyroid carcinoma (MTC)
• Have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
• Are pregnant or breastfeeding
• Have a history of pancreatitis or severe gastrointestinal conditions

Your prescriber will review your full medical history before issuing a prescription.

Wegovy Pill Dosage and How to Take It

The Wegovy pill follows a gradual dose escalation schedule, giving your body time to adjust and reducing the likelihood of side effects. The four available tablet strengths are:

• 1.5mg — starting dose
• 4mg
• 9mg
• 25mg — maintenance dose

You increase your dose every four weeks, or longer if needed. Most people reach the full 25mg maintenance dose after approximately 13 weeks of treatment.

Taking the Tablet Correctly

This step matters more than it might seem. To ensure the semaglutide is properly absorbed:

1. Take the tablet first thing in the morning, before eating or drinking anything else.
2. Use a small sip of plain water only — no more than 120ml.
3. Wait at least 30 minutes before eating, drinking anything other than water, or taking other medicines.

Food, coffee, juice, and other medicines taken too soon can significantly reduce how much semaglutide your body absorbs, affecting the treatment's effectiveness.

Wegovy Pill Side Effects

The side effects of the Wegovy pill are broadly consistent with those seen in injectable semaglutide treatments. Most are mild to moderate and tend to settle as your body adjusts to the medication.

Common Side Effects

• Nausea (slightly more common with the pill than the injection)
• Vomiting
• Diarrhoea and/or constipation
• Abdominal discomfort or bloating

These typically occur during the early weeks of treatment and ease over time. Starting at a low dose and increasing gradually helps to minimise them.

Less Common but Serious Side Effects

Rare but more serious side effects include gallbladder problems (including gallstones), inflammation of the pancreas (pancreatitis), and optic neuropathy a rare condition affecting vision. Around 7% of participants in the OASIS 4 trial discontinued treatment due to adverse events, mostly gastrointestinal in nature.

If you experience severe or persistent side effects, contact your prescriber promptly.

How to Get the Wegovy Pill in the UK

Because the Wegovy pill is a prescription-only medicine, you cannot buy it over the counter. You will need a clinical consultation, either in person or via a regulated online service, before a prescriber can issue a prescription.

At Holroyd Pharmacy, our experienced team can guide you through the consultation process, assess your eligibility, and support you throughout your treatment. We are committed to making evidence-based weight management treatment accessible to patients who can genuinely benefit from it.

The Wegovy pill is not currently available on the NHS. Any NHS rollout will depend on NICE completing its cost-effectiveness review a process that typically takes months to years. Private pharmacies remain the primary route of access in the UK at present.

Frequently Asked Questions

Is the Wegovy weight loss pill available in the UK?

Yes. The MHRA approved the Wegovy pill on 11 June 2026, making the UK the first country in Europe to license an oral GLP-1 receptor agonist for weight loss. It is currently available only on a private prescription basis. NHS coverage is subject to a separate review by NICE, which has not yet concluded.

How much weight can you lose on the Wegovy pill?

Clinical trial results from the OASIS 4 study show participants lost an average of 16.6% of their body weight over 64 weeks. Around one in three people lost 20% or more. Results vary depending on starting weight, how closely you follow dietary and lifestyle guidance, and how your body responds to treatment.

Is the Wegovy pill better than the Wegovy injection?

Both contain the same active ingredient semaglutide and deliver comparable results. The standard injection dose produced 17.5% weight loss over 72 weeks, compared to 16.6% for the pill over 64 weeks. The main difference is practical: the pill is taken daily as a tablet, while the injection is given once a week. If needles are a barrier, the pill is an excellent alternative.

What are the main side effects of the Wegovy pill?

The most common side effects are gastrointestinal: nausea, vomiting, diarrhoea, constipation, and abdominal discomfort. These tend to be mild to moderate and often improve as your body adjusts. Starting on the lowest dose and increasing gradually helps minimise them. Rare but serious risks include pancreatitis and gallbladder problems, which is why medical supervision is essential throughout treatment.

Can I switch from the Wegovy injection to the Wegovy pill?

Yes, switching is possible. If you are currently on the injectable Wegovy, your prescriber can advise on the appropriate pill dose to switch to. Generally, you would begin the pill one week after your last injection, starting at a dose that corresponds to your current injectable dose. Always make any switch under the guidance of a qualified prescriber.

Conclusion

The Wegovy weight loss pill marks a genuine turning point in the treatment of obesity in the UK. For the first time, people who want the proven benefits of semaglutide without the need for weekly self-injections have a licensed, clinically validated option. With an average weight loss of 16.6% over 64 weeks, the results speak for themselves.

That said, no medication works in isolation. The Wegovy pill is most effective when taken correctly and paired with sustainable dietary changes, increased physical activity, and regular check-ins with a healthcare professional. It is a powerful tool not a shortcut.

If you think the Wegovy pill could be right for you, the next step is a consultation with a qualified prescriber who can assess your eligibility and answer your individual questions.

Ready to Take the Next Step?

Holroyd Pharmacy is here to help. Whether you are new to weight management treatment or looking to explore your options, our knowledgeable team can provide expert guidance from consultation through to ongoing support.

👉 Contact Holroyd Pharmacy today to find out whether the Wegovy weight loss pill is suitable for you.